Drug Antiseptics

Hibiclens

Payments companies reported to CMS as associated with Hibiclens. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,842associated payments (2023-2025)
35clinicians with associated payments
1company reporting

By year

2023 $1,019
2024 $1,858
2025 $966

Payments reported as associated with Hibiclens, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Family $763
Critical Care Medicine (Registered Nurse) $696
Adult Health (Nurse Practitioner) $496
Pediatrics (Nurse Practitioner) $468
Nurse Practitioner $276
Critical Care Medicine (Clinical Nurse Specialist) $201

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hibiclens

These are the largest totals companies reported as associated with Hibiclens. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Tracy Spitzer Greenwood, IN Critical Care Medicine (Registered Nurse) $696.00
Dorothy Beke Dedham, MA Pediatrics (Nurse Practitioner) $247.53
Elizabeth Day Chicago, IL Critical Care Medicine (Clinical Nurse Specialist) $200.67
Taramattee Jagnatnarain South Richmond Hill, NY Adult Health (Nurse Practitioner) $151.50
Teresa Washington Beachwood, OH Adult Health (Nurse Practitioner) $150.05
Jayson Santiago Santa Rosa, CA Acute Care (Nurse Practitioner) $140.00
Sally Strong Redwood City, CA Family $140.00
Karen Wiercinski Orlando, FL Registered Nurse $139.39
Andrea Williams Kissimmee, FL Family $139.39
Richard Laux Pittsburgh, PA Nurse Anesthetist, Certified Registered $135.53

Prescribed Hibiclens?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.